Two-stage hepatectomy (R0) with portal vein ligation - Towards curing patients with extended bilobular colorectal liver metastases

International Journal of Colorectal Disease

Volumn 24, Issue 4, 2009, Pages 409-418

  Homayounfar, K ^a   Liersch, T ^a   Schuetze, G ^a   Niessner, M ^a   Goralczyk, A ^a   Meller, J ^a   Langer, C ^a   Ghadimi, B M ^a   Becker, H ^a   Lorf, T ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Bilobular colorectal liver metastases; Insufficient future remnant liver volume; Liver hypertrophy; Portal vein ligation; Two stage hepatectomy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LABETUZUMAB; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MULTIMODALITY CANCER THERAPY; PILOT STUDY; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; VEIN LIGATION;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIGATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61549084664     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0620-z     Document Type: Article

References (42)

1. Abdalla E, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-827
2. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318
3. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W et al (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703-710
4. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
5. Adam R (2003) Chemotherapy and surgery: New perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(S2):iI13-16
6. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P (2004) A Two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobular colorectal liver metastases. Ann Surg 240:1037-1051
7. Gruttadauria S, Vasta F, Mivervini MI, Piazza T, Arcadipane A, Marcos A et al (2005) Significance of the effective remnant liver volume in major hepatectomies. Am Surg 71:235-240
8. Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O et al (2007) Remnant liver volume to body weight ratio >0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22-33
9. Adam R, Delvart V, Pascal G, Azoulay D, Delvart V, Paule B et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240(6):644-657
10. Rous P, Larimore LD (1920) Relation of the portal blood to liver maintenance. J Exp Med 31:609-632
11. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231(4):480-486
12. Shaw IM, Rees M, Welsh FKS, Bygrave S, John TG (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term-survival. Br J Surg 93:457-464
13. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: The third hepatectomy. Ann Surg 238(6):871-883
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
15. Elias D, de Baere T, Roche A, Ducreux M, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784-788
16. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M et al (2001) Proliferative acitivity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-272
17. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The "50-50 criteria" on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824-829
18. Goldenberg DM, Sharkey RM, Primus FJ (1976) Carcinoembryonic antigen in histopathology: Immunoperoxidase staining of conventional tissue sections. J Natl Cancer Inst 57:11-22
19. Gold P, Goldenberg NA (1997) The carcinoembryonic antigen (CEA): Past present, and future. McGill J Med 3:46-66
20. Goldenberg DM, Kim EE, DeLand FH, Bennett S, Primus FJ (1980) Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 40:2984-2992
21. Moffat FL Jr, Pinsky CM, Hammershaimb L, Petrelli NJ, Patt YZ, Whaley FS et al (1996) Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99 m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal, phase III trial. The Immunomedics Study Group. J Clin Oncol 14(8):2295-2305
22. Liersch T, Meller J, Kulle B, Behr TM, Markus P, Langer C et al (2005) Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: Five-year safety and efficacy results. J Clin Oncol 23(27):6763-6770
23. Liersch T, Meller J, Bittrich M, Kulle B, Becker H, Goldenberg DM (2007) Update of carcinoembryonic antigen radioimmunotherapy with (131)i-labetuzumab after salvage resection of colorectal liver metastases: Comparison of outcome to a contemporaneous control group. Ann Surg Oncol 14:2577-2590
24. Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG et al (2002) Portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6(6):905-913
25. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N et al (2007) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12(2):297-303 (Epub 2007 Nov 30)
26. Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA (2006) Accuracy of preoperative imaging of hepatic tumours with helical computed tomography. Ann Surg Oncol 13:542-546
27. Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, Jochum W et al (2007) Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. J Clin Ultrasound 36(1):20-26
28. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L (2007) Challenges in everyday surgical practice: Synchronous bilobular hepatic colorectal metastases - newer multimodality approach. Hepatogastroenterology 54:1020-1024
29. Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197(2):233-241
30. van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F et al (2006) Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 13(5):651-658
31. Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC (2008) Radiofrequency ablation for metachronous liver metastases from colorectal cancer after curative surgery. Ann Surg Oncol 15:227-232
32. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15(3):460-466
33. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243(1):1-7
34. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24(13):2065-2072
35. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22(2):229-237
36. Selzner N, Pestalozzi BC, Kadry Z, Selzner M, Wildermuth S, Clavien PA (2006) Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J Surg 93:587-92
37. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H (2007) Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterology 15:34
38. Makuuchi M, Hashikura Y, Kawasaki S, Tan D, Kosuge T, Takayama T (1993) Personal experience of right anterior segmentectomy (segments V and VIII) for hepatic malignancies. Surgery 114(1):52-58
39. Elias D, Santoro R, Ouellet JF, Osmak L, de Baere T, Roche A (2004) Simultaneous percutaneous right portal vein embolization and left tumour radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepato-gastroenterol 51(60):1788-1791
40. Folprecht G, Grothey A, Alberts S, Raab HR, Koehne CH (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates. Ann Oncol 16(8):1311-1319
41. Mitry E, Fields ALA, Bleiberg H, Labianca R, Portier G, Tu D et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: A pooled analysis of two randomized trials. J Clin Oncol 26(30):4906-4911
42. Covey AM, Brody LA, Getrajdman GI, Sofocleus CT, Brown KT (2004) Incidence, patterns, and clinical relevance of variant portal vein anatomy. Am J Roentgenol 183(4):1055-1064